These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27766622)

  • 1. Outcome of primary cutaneous anaplastic large cell lymphoma: a 20-year British Columbia Cancer Agency experience.
    Hapgood G; Pickles T; Sehn LH; Villa D; Klasa R; Scott DW; Gerrie AS; Gascoyne RD; Slack GW; Parsons C; Morris JW; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):234-240. PubMed ID: 27766622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in primary cutaneous anaplastic large cell lymphoma: characterization of clinical subset with worse outcome.
    Woo DK; Jones CR; Vanoli-Storz MN; Kohler S; Reddy S; Advani R; Hoppe RT; Kim YH
    Arch Dermatol; 2009 Jun; 145(6):667-74. PubMed ID: 19528422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALK-positive primary cutaneous anaplastic large cell lymphoma: a case report and review of the literature.
    Geller S; Canavan TN; Pulitzer M; Moskowitz AJ; Myskowski PL
    Int J Dermatol; 2018 May; 57(5):515-520. PubMed ID: 29057463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of treatment results in multifocal primary cutaneous anaplastic large cell lymphoma: report of the Dutch Cutaneous Lymphoma Group.
    Melchers RC; Willemze R; Bekkenk MW; de Haas ERM; Horvath B; van Rossum MM; Sanders CJG; Veraart JCJM; Vermeer MH; Quint KD
    Br J Dermatol; 2018 Sep; 179(3):724-731. PubMed ID: 29494757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary cutaneous anaplastic large cell lymphoma: clinical presentation, therapy and prognosis study of 10 cases].
    Lü Z; Shi YK; He XH; Qin Y; Zhou SY; Zhang CG; Liu P; Yang JL
    Zhonghua Yi Xue Za Zhi; 2010 May; 90(18):1247-50. PubMed ID: 20646596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.
    Kridel R; Telio D; Villa D; Sehn LH; Gerrie AS; Shenkier T; Klasa R; Slack GW; Tan K; Gascoyne RD; Connors JM; Savage KJ
    Br J Haematol; 2017 Jan; 176(2):210-221. PubMed ID: 27739058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous marginal zone B-cell lymphoma: response to treatment and disease-free survival in a series of 137 patients.
    Servitje O; Muniesa C; Benavente Y; Monsálvez V; Garcia-Muret MP; Gallardo F; Domingo-Domenech E; Lucas A; Climent F; Rodriguez-Peralto JL; Ortiz-Romero PL; Sandoval J; Pujol RM; Estrach MT
    J Am Acad Dermatol; 2013 Sep; 69(3):357-65. PubMed ID: 23796549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localized mucosa-associated lymphoid tissue lymphoma treated with radiation therapy has excellent clinical outcome.
    Tsang RW; Gospodarowicz MK; Pintilie M; Wells W; Hodgson DC; Sun A; Crump M; Patterson BJ
    J Clin Oncol; 2003 Nov; 21(22):4157-64. PubMed ID: 14615444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency.
    Shenkier TN; Voss N; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Klimo P; O'Reilly SE; Sutcliffe S; Connors JM
    J Clin Oncol; 2002 Jan; 20(1):197-204. PubMed ID: 11773170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited-stage diffuse large B-cell lymphoma treated with abbreviated systemic therapy and consolidation radiotherapy: involved-field versus involved-node radiotherapy.
    Campbell BA; Connors JM; Gascoyne RD; Morris WJ; Pickles T; Sehn LH
    Cancer; 2012 Sep; 118(17):4156-65. PubMed ID: 22252721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of tonsillar lymphoma: a 10-year experience.
    Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
    Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult Dermal Lymphatic Involvement Is Frequent in Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Gratzinger D; Million L; Kim YH
    Am J Dermatopathol; 2015 Oct; 37(10):767-70. PubMed ID: 26381026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous anaplastic large cell lymphoma with angioinvasive features and cytotoxic phenotype: a rare lymphoma variant within the spectrum of CD30+ lymphoproliferative disorders.
    Kempf W; Kazakov DV; Paredes BE; Laeng HR; Palmedo G; Kutzner H
    Dermatology; 2013; 227(4):346-52. PubMed ID: 24246691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-dose radiotherapy for primary cutaneous anaplastic large-cell lymphoma while on low-dose methotrexate.
    Cornejo CM; Novoa RA; Krisch RE; Kim EJ
    Cutis; 2016 Oct; 98(4):253-256. PubMed ID: 27874877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary cutaneous non-Hodgkin's lymphoma of Ann Arbor stage I: preferential cutaneous relapses but high cure rate with doxorubicin-based therapy.
    Sarris AH; Braunschweig I; Medeiros LJ; Duvic M; Ha CS; Rodriguez MA; Hagemeister FB; McLaughlin P; Romaguera J; Cox J; Cabanillas F
    J Clin Oncol; 2001 Jan; 19(2):398-405. PubMed ID: 11208831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and outcomes of primary breast lymphoma.
    Caon J; Wai ES; Hart J; Alexander C; Truong PT; Sehn LH; Connors JM
    Clin Breast Cancer; 2012 Dec; 12(6):412-9. PubMed ID: 23018097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognosis and treatment strategies of primary B-cell and NK/T-cell nasopharyngeal non-Hodgkin's lymphoma at early stage].
    Zou GR; Zhang YJ; Xie FY; Zheng W; Li HX; Xia YF; Lin TY; Lu TX
    Ai Zheng; 2006 Dec; 25(12):1543-9. PubMed ID: 17166383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in patients with primary cutaneous anaplastic large cell lymphoma: a multicentric, retrospective analysis of the Spanish Group of Cutaneous Lymphoma.
    Fernández-de-Misa R; Hernández-Machín B; Combalía A; García Muret MP; Servitje O; Muniesa C; Gallardo F; Pujol RM; Martí RM; Ortiz-Brugués A; Maroñas-Jiménez L; Ortiz-Romero PL; Blanch Rius L; Izu R; Román C; Cañueto J; Blanes M; Morillo M; Bastida J; Peñate Y; Pérez Gala S; Espinosa Lara P; Pérez Gil A; Estrach T
    J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):762-768. PubMed ID: 31591786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nodular lymphocyte predominant Hodgkin lymphoma in the modern era.
    King MT; Donaldson SS; Link MP; Natkunam Y; Advani RH; Hoppe RT
    Int J Radiat Oncol Biol Phys; 2015 May; 92(1):67-75. PubMed ID: 25863755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy of primary cutaneous anaplastic large cell lymphoma: our experience in 30 cases.
    Piccinno R; Damiani G; Rossi LC; Berti E
    Int J Dermatol; 2020 Apr; 59(4):469-473. PubMed ID: 31916593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.